Published in Seizure on December 01, 2001
Thalamus lesions in chronic and acute seizure disorders. Neuroradiology (2010) 0.90
Prolonged refractory status epilepticus with early and persistent restricted hippocampal signal MRI abnormality. J Neurol (2008) 0.89
Claustrum damage and refractory status epilepticus following febrile illness. Neurology (2015) 0.86
Immunity and inflammation in status epilepticus and its sequelae: possibilities for therapeutic application. Expert Rev Neurother (2015) 0.80
Unusual lesion in the bilateral external capsule following status epilepticus: a case report. J Epilepsy Res (2014) 0.79
New-Onset Refractory Status Epilepticus with Claustrum Damage: Definition of the Clinical and Neuroimaging Features. Front Neurol (2017) 0.75
Sequence organization of the spacer DNA in a ribosomal gene unit of Xenopus laevis. Cell (1979) 3.96
A transcriptional function for the repetitive ribosomal spacer in Xenopus laevis. Nature (1983) 3.80
Short-range DNA looping by the Xenopus HMG-box transcription factor, xUBF. Science (1994) 3.57
Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer (2006) 3.23
More ribosomal spacer sequences from Xenopus laevis. Nucleic Acids Res (1980) 2.50
Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol (2000) 2.37
An immediate response of ribosomal transcription to growth factor stimulation in mammals is mediated by ERK phosphorylation of UBF. Mol Cell (2001) 2.35
The promotion of ribosomal transcription in eukaryotes. Oxf Surv Eukaryot Genes (1985) 2.18
Studies on the role and mode of operation of the very-lysine-rich histone H1 in eukaryote chromatin. The three structural regions of the histone H1 molecule. Eur J Biochem (1977) 2.14
The putative promoter of a Xenopus laevis ribosomal gene is reduplicated. Nucleic Acids Res (1979) 2.07
Transcription of cloned Xenopus laevis ribosomal DNA microinjected into Xenopus oocytes, and the identification of an RNA polymerase I promoter. Cell (1982) 2.05
The RNA polymerase I transcription factor xUBF contains 5 tandemly repeated HMG homology boxes. Nucleic Acids Res (1991) 2.03
The internet. J Neurol Neurosurg Psychiatry (2002) 1.86
Sporadic Creutzfeldt-Jakob disease in a 18-year-old in the UK. Lancet (1995) 1.76
Teflon-induced granuloma following treatment of trigeminal neuralgia by microvascular decompression. Report of two cases. J Neurosurg (1997) 1.68
Spacer promoters are essential for efficient enhancement of X. laevis ribosomal transcription. Cell (1986) 1.64
Competitive recruitment of CBP and Rb-HDAC regulates UBF acetylation and ribosomal transcription. Mol Cell (2000) 1.47
A complex array of sequences enhances ribosomal transcription in Xenopus laevis. J Mol Biol (1987) 1.44
High-resolution proton-magnetic-resonance studies of chromatin core particles. Eur J Biochem (1978) 1.44
The ribosomal spacer in Xenopus laevis is transcribed as part of the primary ribosomal RNA. Nucleic Acids Res (1986) 1.41
The effect of raised intracranial pressure on intracochlear fluid pressure: three case studies. Br J Audiol (1987) 1.40
Congenital astroblastoma: an immunohistochemical study. Case report. J Neurosurg (1995) 1.39
A pH-dependent interaction between histones H2A and H2B involving secondary and tertiary folding. Eur J Biochem (1976) 1.37
Affinity purification of mammalian RNA polymerase I. Identification of an associated kinase. J Biol Chem (1998) 1.21
DNA looping in the RNA polymerase I enhancesome is the result of non-cooperative in-phase bending by two UBF molecules. Nucleic Acids Res (2001) 1.19
The enhancement of ribosomal transcription by the recycling of RNA polymerase I. Nucleic Acids Res (1987) 1.17
Recognition of the Xenopus ribosomal core promoter by the transcription factor xUBF involves multiple HMG box domains and leads to an xUBF interdomain interaction. EMBO J (1993) 1.17
Physical studies on the H3/H4 histone tetramer. Biochemistry (1976) 1.15
Probing the kinetics of formation of the bacteriophage MS2 translational operator complex: identification of a protein conformer unable to bind RNA. J Mol Biol (2001) 1.06
Shed tumor gangliosides and progression of human neuroblastoma. Blood (1990) 1.05
5'-Labeling and poly(dA) tailing. Methods Enzymol (1980) 1.04
Identification of a mammalian RNA polymerase I holoenzyme containing components of the DNA repair/replication system. Nucleic Acids Res (1999) 1.04
Overexpression of the transcription factor UBF1 is sufficient to increase ribosomal DNA transcription in neonatal cardiomyocytes: implications for cardiac hypertrophy. Proc Natl Acad Sci U S A (1996) 1.03
Dose-response effect of fetal cocaine exposure on newborn neurologic function. Pediatrics (1999) 1.00
Heterogeneity in the Xenopus ribosomal transcription factor xUBF has a molecular basis distinct from that in mammals. FEBS Lett (1991) 0.99
A scoring system for states of sleep and wakefulness in term and preterm infants. Pediatr Res (1984) 0.99
Mutation analysis in patients with possible but apparently sporadic Huntington's disease. Lancet (1994) 0.99
Gadolinium-labeled liposomes: targeted MR contrast agents for the liver and spleen. Radiology (1987) 0.99
Dimensions of LSD, methylphenidate and chlordiazepoxide experiences. Psychopharmacologia (1969) 0.97
A nucleosome-like structure containing DNA and the arginine-rich histones H3 and H4. Nucleic Acids Res (1977) 0.96
Red cell sodium in hyperthyroidism. Br Med J (1971) 0.96
Cellular regulation of ribosomal DNA transcription:both rat and Xenopus UBF1 stimulate rDNA transcription in 3T3 fibroblasts. Nucleic Acids Res (1999) 0.95
Structural basis of pyrimidine specificity in the MS2 RNA hairpin-coat-protein complex. RNA (2001) 0.95
The DNA supercoiling architecture induced by the transcription factor xUBF requires three of its five HMG-boxes. Nucleic Acids Res (1996) 0.93
Exercise enhances creativity independently of mood. Br J Sports Med (1997) 0.92
Immunization information systems progress - United States, 2005. MMWR Morb Mortal Wkly Rep (2006) 0.92
Event-related potentials--neurophysiological tools for predicting emergence and early outcome from traumatic coma. Intensive Care Med (1996) 0.91
Malignant transformation of posterior fossa epidermoid cyst. Br J Neurosurg (2005) 0.91
Focal retrograde amnesia: a long term clinical and neuropsychological follow-up. Cortex (1989) 0.90
Packed red blood cell transfusion is an independent risk factor for necrotizing enterocolitis in premature infants. J Perinatol (2013) 0.90
The Xenopus laevis ribosomal gene terminator contains sequences that both enhance and repress ribosomal transcription. Mol Cell Biol (1989) 0.88
Nucleosomes, histone interactions, and the role of histones H3 and H4. Cold Spring Harb Symp Quant Biol (1978) 0.88
Human hemopexin. Preparation and magnetic properties. J Biol Chem (1974) 0.88
Sites of histone/histone interaction in the H3 - H4 complex. Eur J Biochem (1977) 0.87
DNase I footprinting. Methods Mol Biol (2001) 0.86
DNase I footprinting. Methods Mol Biol (1994) 0.85
High resolution studies of the Xenopus laevis ribosomal gene promoter in vivo and in vitro. J Biol Chem (1992) 0.84
Harmful aspects of the LSD experience. J Nerv Ment Dis (1967) 0.84
Variants of the Xenopus laevis ribosomal transcription factor xUBF are developmentally regulated by differential splicing. Nucleic Acids Res (1992) 0.83
Immunocytochemical evidence of lymphocytic derivation of neoplastic cells in malignant angioendotheliomatosis. J Neurosurg (1991) 0.83
Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA. Chromosoma (1996) 0.83
UV laser-induced protein-DNA crosslinking. Methods Mol Biol (1994) 0.82
Enzymatic removal of vitelline membrane and other protocol modifications for whole mount in situ hybridization of Xenopus embryos. Trends Genet (1996) 0.82
Profile of placental alkaline phosphatase expression in human malignancies: effect of tumour cell activation on alkaline phosphatase expression. Urol Int (1999) 0.82
Concordance between tumour cell activation by epidermal growth factor and alteration of cell sensitivity to cisplatin and lymphokine-activated killer cell activity. Oncol Rep (2000) 0.81
Left ventricular thrombi in a patient with the antiphospholipid syndrome. Br Heart J (1995) 0.81
Cervical lymph nodes metastases from a pituitary carcinoma. Br J Neurosurg (1994) 0.80
Large-scale immunomagnetic separation system for the removal of tumor cells from bone marrow. Prog Clin Biol Res (1992) 0.80
A ribosomal orphon sequence from Xenopus laevis flanked by novel low copy number repetitive elements. Biol Chem (1999) 0.80
Mapping of a sequence essential for the nuclear transport of the Xenopus ribosomal transcription factor xUBF using a simple coupled translation-transport and acid extraction approach. DNA Cell Biol (1993) 0.79
X-linked bulbo-spinal neuronopathy: a family study of three patients. J Neurol Neurosurg Psychiatry (1987) 0.79
Catalytic and non-catalytic forms of the neurotrophin receptor xTrkB mRNA are expressed in a pseudo-segmental manner within the early Xenopus central nervous system. Int J Dev Biol (1996) 0.79
Point mutation analysis of the Xenopus laevis RNA polymerase I core promoter. Nucleic Acids Res (1990) 0.79
The cytoskeletal effector xPAK1 is expressed during both ear and lateral line development in Xenopus. Int J Dev Biol (2000) 0.79
A randomised, double-blind, parallel group study to compare subcutaneous interferon alpha-2a plus podophyllin with placebo plus podophyllin in the treatment of primary condylomata acuminata. Genitourin Med (1994) 0.79
Metastasizing meningioma. Neurosurgery (1986) 0.79
Mutations in the laminin alpha2-chain gene in two children with early-onset muscular dystrophy. Brain (2000) 0.79
Biochemical cure of recurrent acromegaly by resection of cervical spinal canal metastases. Clin Endocrinol (Oxf) (1996) 0.79
Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer. Oncogene (2016) 0.78
High-dose chemotherapy in patients with breast cancer: evaluation of infusing peripheral blood stem cells containing occult tumor cells. Bone Marrow Transplant (1998) 0.78
Wandering. Gerontologist (1978) 0.78
Direct injection of 90Y MoAbs into glioma tumor resection cavities leads to limited diffusion of the radioimmunoconjugates into normal brain parenchyma: a model to estimate absorbed radiation dose. Int J Radiat Oncol Biol Phys (1998) 0.77
Reticulate hyperpigmentation of the skin after topical application of benzoyl peroxide. Acta Derm Venereol (1998) 0.77
Cerebral distribution of immunoconjugate after treatment for neoplastic meningitis using an intrathecal radiolabeled monoclonal antibody. Neurosurgery (1989) 0.77
Dexamethasone can stimulate G1-S phase transition in human airway fibroblasts in asthma. Eur Respir J (2006) 0.77
Comparison of three silver stains for demonstrating neurofibrillary tangles and neuritic plaques in brain tissue stored for long periods. Acta Neuropathol (1990) 0.77
A new human (psycho)pharmacology tool: the multiple organs coincidences counter (MOCC). J Psychopharmacol (1995) 0.77
Spontaneous variability in minute ventilation oxygen consumption and heart rate of low birth weight infants. Pediatr Res (1981) 0.76
Oculographic findings in traumatic unconsciousness: prognostic implications. J Neurol Neurosurg Psychiatry (1995) 0.76
Phylogenetic analysis of multiple heterosexual transmission events involving subtype b of HIV type 1. AIDS Res Hum Retroviruses (2001) 0.76
The effect of neuraxial steroids on weight and bone mass density: a prospective evaluation. Pain Physician (2000) 0.75
UV laser-induced protein-DNA crosslinking. Methods Mol Biol (2001) 0.75
Non-sexual transmission of HIV. Int J STD AIDS (2004) 0.75
Minimal-change glomerulonephritis associated with circulating anticoagulant to factor XII. Br Med J (1980) 0.75
DNA tailing without terminal transferase. Nucleic Acids Res (1988) 0.75
A method of studying pharmacokinetics in man at picomolar drug concentrations. Br J Clin Pharmacol (1991) 0.75
Hypnosis and ESP: a controlled experiment. Am J Clin Hypn (1970) 0.75
ESP effects generated by affective states. Behav Neuropsychiatry (1971) 0.75
A laboratory investigation of telepathy: the study of a psychic. Behav Neuropsychiatry (1976) 0.75
Characteristics of alcoholics volunteering for lysergide treatment. Q J Stud Alcohol (1970) 0.75